FDA Approves First Two-Drug Combo for HIV

Source: The Telegraph

Nov 26, 2017

GlaxoSmithKline has been granted U.S. FDA approval for the world's first two-drug regimen to treat HIV.

The once-daily pill, Juluca, combines two previously approved drugs — dolutegravir and rilpivirine. The treatment is produced by ViiV Healthcare, a HIV specialist business majority-owned by GSK.

The current treatments for HIV involve combining three or four medicines and have multiple side effects. GSK and rival Gilead are both testing numerous simpler, more effective HIV treatments.

Read the Telegraph coverage


Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments